MicroRNA-148a Reduces Tumorigenesis and Increases TRAIL-induced Apoptosis in NSCLC

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2015 Jul 1

PMID 26124099

Citations 51

Authors

Pooja Joshi

Young-Jun Jeon

Alessandro Lagana

Justin Middleton

Paola Secchiero

Michela Garofalo

Carlo M Croce

Affiliations

Soon will be listed here.

Abstract

Nonsmall cell lung cancer (NSCLC) is one of the leading causes of death worldwide. TNF-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in malignant cells without inducing significant toxicity in normal cells. However, several carcinomas, including lung cancer, remain resistant to TRAIL. MicroRNAs (miRNAs) are small noncoding RNAs of ∼ 24 nt that block mRNA translation and/or negatively regulate its stability. They are often aberrantly expressed in cancer and have been implicated in increasing susceptibility or resistance to TRAIL-induced apoptosis by inhibiting key functional proteins. Here we show that miR-148a is down-regulated in cells with acquired TRAIL-resistance compared with TRAIL-sensitive cells. Enforced expression of miR-148a sensitized cells to TRAIL and reduced lung tumorigenesis in vitro and in vivo through the down-modulation of matrix metalloproteinase 15 (MMP15) and Rho-associated kinase 1 (ROCK1). These findings suggest that miR-148a acts as a tumor suppressor and might have therapeutic application in the treatment of NSCLC.

Citing Articles

and regulate TRAIL-induced drug tolerance in lung cancer.

Kim S, Lee K, Yoo Y, Park S, Lee J, Jeon S Anim Cells Syst (Seoul). 2024; 28(1):184-197.

PMID: 38693921 PMC: 11062278. DOI: 10.1080/19768354.2024.2345644.

Role of microRNA-494 in tumor progression.

Maharati A, Akhlaghipour I, Taghehchian N, Yazdi Z, Moghbeli M Am J Transl Res. 2023; 15(11):6342-6361.

PMID: 38074823 PMC: 10703645.

miRNA in Molecular Diagnostics.

Matulic M, Grskovic P, Petrovic A, Begic V, Harabajsa S, Korac P Bioengineering (Basel). 2022; 9(9).

PMID: 36135005 PMC: 9495386. DOI: 10.3390/bioengineering9090459.

MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.

Zhang N, Zhou J, Zhou Y, Guan F Appl Biochem Biotechnol. 2022; 194(6):2731-2746.

PMID: 35267120 DOI: 10.1007/s12010-022-03863-2.

miR-148a promotes cell sensitivity through downregulating SOS2 in radiation-resistant non-small cell lung cancer cells.

Zhang Y, Hu X Oncol Lett. 2022; 23(4):135.

PMID: 35251354 PMC: 8895464. DOI: 10.3892/ol.2022.13255.

References

Garofalo M, Di Leva G, Romano G, Nuovo G, Suh S, Ngankeu A . RETRACTED: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell. 2009; 16(6):498-509. PMC: 2796583. DOI: 10.1016/j.ccr.2009.10.014. View

Hou J, Aerts J, den Hamer B, van IJcken W, den Bakker M, Riegman P . Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PLoS One. 2010; 5(4):e10312. PMC: 2858668. DOI: 10.1371/journal.pone.0010312. View

Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C . miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 2010; 70(9):3638-46. DOI: 10.1158/0008-5472.CAN-09-3341. View

Somlyo A, Bradshaw D, Ramos S, Murphy C, Myers C, Somlyo A . Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem Biophys Res Commun. 2000; 269(3):652-9. DOI: 10.1006/bbrc.2000.2343. View

Morrison C, Butler G, Bigg H, Roberts C, Soloway P, Overall C . Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem. 2001; 276(50):47402-10. DOI: 10.1074/jbc.M108643200. View

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

Nyormoi O, Mills L, Bar-Eli M . An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ. 2003; 10(5):558-69. DOI: 10.1038/sj.cdd.4401209. View

Riento K, Ridley A . Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003; 4(6):446-56. DOI: 10.1038/nrm1128. View

Kamai T, Tsujii T, Arai K, Takagi K, Asami H, Ito Y . Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer. Clin Cancer Res. 2003; 9(7):2632-41. View

10.

Krichevsky A, King K, Donahue C, Khrapko K, Kosik K . A microRNA array reveals extensive regulation of microRNAs during brain development. RNA. 2003; 9(10):1274-81. PMC: 1370491. DOI: 10.1261/rna.5980303. View

11.

Chakraborti S, Mandal M, Das S, Mandal A, Chakraborti T . Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003; 253(1-2):269-85. DOI: 10.1023/a:1026028303196. View

12.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

13.

Rhodes D, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D . ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004; 6(1):1-6. PMC: 1635162. DOI: 10.1016/s1476-5586(04)80047-2. View

14.

Ambros V . The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. DOI: 10.1038/nature02871. View

15.

Sahai E, Ishizaki T, Narumiya S, Treisman R . Transformation mediated by RhoA requires activity of ROCK kinases. Curr Biol. 1999; 9(3):136-45. DOI: 10.1016/s0960-9822(99)80067-0. View

16.

Abraham R, Schafer J, Rothe M, Bange J, Knyazev P, Ullrich A . Identification of MMP-15 as an anti-apoptotic factor in cancer cells. J Biol Chem. 2005; 280(40):34123-32. DOI: 10.1074/jbc.M508155200. View

17.

Zhang J, Sarkar S, Yong V . The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase. Carcinogenesis. 2005; 26(12):2069-77. DOI: 10.1093/carcin/bgi183. View

18.

Fesik S . Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 2005; 5(11):876-85. DOI: 10.1038/nrc1736. View

19.

Ishimura N, Isomoto H, Bronk S, Gores G . Trail induces cell migration and invasion in apoptosis-resistant cholangiocarcinoma cells. Am J Physiol Gastrointest Liver Physiol. 2005; 290(1):G129-36. DOI: 10.1152/ajpgi.00242.2005. View

20.

Nagase H, Visse R, Murphy G . Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006; 69(3):562-73. DOI: 10.1016/j.cardiores.2005.12.002. View